Biogen Inc. announced that the U.S. Food and Drug Administration extended the review period of the promising gene therapy treatment Tofersen to consider additional data. The initial review period, which was announced in July 2022, was scheduled to conclude in January 2023. The review will now be extended to April 25, 2023.
The U.S. Food and Drug Administration awarded $3.7 million to three ALS research projects as part of the implementation of the Accelerating Access to Critical Therapies for Amyotrophic Lateral Sclerosis Act (ACT for ALS).
The Arkansas VA ALS Clinic in Little Rock, Arkansas provides focused support for people living with ALS, allowing them to receive care from specialized medical professionals during a single visit.
The Johns Hopkins Center for ALS Specialty Care in Baltimore, Maryland provides focused support for people living with ALS, allowing them to receive care from specialized medical professionals during a single visit.
The Norton Neuroscience Institute ALS Clinic in Louisville, Kentucky provides focused support for people living with ALS, allowing them to receive care from specialized medical professionals during a single visit.
The ALS Association recently announced the creation of a new award to honor “superfans,” the most passionate sports and entertainment fans who are also living with ALS. The award is inspired by Stephen Kauffman, who was diagnosed with ALS in 2012, and was honored in 2021 by the Naismith Memorial Basketball Hall of Fame as a Golden State Warriors superfan.
Medicare open enrollment begins this Saturday, the period when individuals may add, drop, or make changes to their health insurance coverage, with selections remaining in effect for the next full year. Understanding exactly what’s available will help you make the critical decisions you need.
The National Academies of Sciences, Engineering, and Medicine (NAS) is undertaking a study into accelerating the development of treatments and improving quality of life for people with ALS. This is a huge win for the community. The ALS Association led an effort to get Congress to direct NAS to undertake a study on ALS and also fought for $1 million to fund the study.
We filed comments urging the U.S. Department of Health and Human Services Office of Civil Rights to finalize a proposed rule that would strengthen civil rights protections against discrimination on the basis of disability in federal health care programs.